The US Food and Drug Administration (FDA) is considering licensing a fourth dose of the Covid-19 vaccine (second booster dose) this fall. According to a source familiar with the matter, the planning is still in the early stages. The licensing process will depend on ongoing research. Scientists need to determine if the fourth dose improves […]
